More than 3 character to search
The term "empty nose syndrome" (ENS) was first introduced by scientists E. Kern and M. Stenkvist in 1994. That's how they called the condition in some patients after conchotomy — a minor operation resulting from which a part of the nasal cavity is removed.
In 2001, in their publication, E. Moore and E. Kern indicated that the causes of secondary atrophic rhinitis and empty nose syndrome include complete (22% of cases) or partial removal (56%) of the middle and lower nasal sinuses. Such operations are traditionally performed in the following cases:
We offer treatment of ENS with the use of biotechnological materials and multipotent stem cells.
The programs of therapy are selected individually for each case. Defects of the nasal sinuses and the patient's health are necessarily taken into account.
1. Intranasal injection of cells derived from the neural crest.
This method improves the nourishment of the nasal mucosa and stimulates the restoration of normal receptor function. This approach reduces the intensity of symptoms of ENS, including psychological.
2. Autologous fat transplantation.
3. Intranasal injection of the three-component graft with methylcellulose, cell-free lyophilized adipose tissue matrix, and mesenchymal stem cells. This innovative method, which was specially developed by the team of GOOD CELLS biotechnologists, is used to correct the volume of the nasal sinuses.
The second and third methods help to restore the physiological aerodynamics in the nasal passages and harmonize breathing.
You are not alone with your problem. There is a chance for improvement!
ENS is a condition that develops after surgery in the area of the nasal sinuses. Herewith physiologically necessary functions of a nose are broken:
The most common complaint of patients with ENS is related to the last point.
"The illusion of nose absence", "discomfort that is almost impossible to live with", "suffocation from which is no escape" — are the frequent descriptions of pathology given by people who have experienced it.
Such people almost always have sleep problems, constant anxiety, and, as a result, nervous system overload, autonomic dysfunction, and cerebrastenic syndrome.
Besides, patients often experience the following symptoms:
● dryness of the nasal mucosa;
● crust formation;
● swelling and pain in the nose;
● headache and dizziness;
● decreased sensitivity of smell and taste;
● chronic fatigue;
● mood swings and irritability.
The price of the program starts from $5,000 and it includes:
Stem Cell Therapy Effects:
It is necessary to approach the treatment of ENS comprehensively. It is often necessary to restore not only the functionality of tissues but also their volume. Reducing the load on the nervous system is an essential part of therapy as well.
For ENS treatment, we use intranasal administration of multipotent stem cells derived from the neural crest.
This procedure improves the function of epithelial cells and reduces inflammatory reactions. Due to this, the damaged mucous membrane of the nasal sinuses is restored.
Partial restoration of morphology:
In cases where the connective tissue and the morphology of the damaged tissues are severely damaged, we use additional approaches:
1. Intranasal injection of adipose mesenchymal stem cells.
It has an anti-inflammatory effect and improves the structure of nasal tissues.
2. Use of biotechnological implants.
They can be of different origin: autologous fat, bone crumbs, or bone chips. In some cases, these materials are supplemented with synthetic components.
This therapy is able to compensate for the volume of nasal tissues, reduce inflammation and swelling, improve the functioning of the mucous membrane and increase its sensitivity.
To learn more about the package, click the button below: